Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)
Status:
Withdrawn
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Patients who is scheduled elective PCI are randomized to pitavastatin 4mg daily or without
pitavastatin for 5 -7days before the procedure. Creatine kinase-MB, troponin I, and myoglobin
levels are measured at baseline and at 8 and 24 hours after the procedure(1st evaluation).
After PCI, pitavastatin will be administered for additional 4 weeks(2nd evaluation).